PTSD is not the emblematic disorder of the COVID-19 pandemic; adjustment disorder is.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
28 04 2022
Historique:
received: 12 11 2021
accepted: 29 03 2022
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 3 5 2022
Statut: epublish

Résumé

Posttraumatic stress disorder (PTSD) has been hailed by some as the emblematic mental disorder of the COVID-19 pandemic, assuming that PTSD's life-threat criterion was met de facto. More plausible outcomes like adjustment disorder (AD) have been overlooked. An online cross-sectional survey was launched in the initial stage of the pandemic using a convenience sample of 5 913 adults to compare the prevalence of COVID-related probable PTSD versus probable AD. The abridged Impact of Event Scale - Revised (IES-6) assessed the severity of trauma- and stressor-related symptoms over the previous week. Demographic and pandemic-related data (e.g., receiving a formal diagnosis of COVID-19, job loss, loss of loved one, confinement, material hardship) were collected. A Classification and Regression Tree analysis was conducted to uncover the pandemic experiences leading to clinical 'caseness'. Caseness was defined by a score > 9 on the IES-6 symptom measure and further characterized as PTSD or AD depending on whether the Peritraumatic Distress Inventory's life-threat item was endorsed or not. The participants were predominantly Caucasian (72.8%), women (79.2%), with a university degree (85%), and a mean age of 42.22 (SD = 15.24) years; 3 647 participants (61.7%; 95%CI [60.4, 63.0]) met the threshold for caseness. However, when perceived life-threat was accounted for, only 6.7% (95%CI [6.1, 7.4]) were classified as PTSD cases, and 55% (95%CI [53.7, 56.2]) as AD cases. Among the AD cases, three distinct profiles emerged marked by the following: (i) a worst personal pandemic experience eliciting intense fear, helplessness or horror (in the absence, however, of any life-threat), (ii) a pandemic experience eliciting sadness/grief, and (iii) worrying intensely about the safety of significant others. Studies considering the life-threat criterion as met de facto during the pandemic are confusing PTSD for AD on most counts. This misconception is obscuring the various AD-related idioms of distress that have emerged during the pandemic and the actual treatment needs.

Sections du résumé

BACKGROUND
Posttraumatic stress disorder (PTSD) has been hailed by some as the emblematic mental disorder of the COVID-19 pandemic, assuming that PTSD's life-threat criterion was met de facto. More plausible outcomes like adjustment disorder (AD) have been overlooked.
METHODS
An online cross-sectional survey was launched in the initial stage of the pandemic using a convenience sample of 5 913 adults to compare the prevalence of COVID-related probable PTSD versus probable AD. The abridged Impact of Event Scale - Revised (IES-6) assessed the severity of trauma- and stressor-related symptoms over the previous week. Demographic and pandemic-related data (e.g., receiving a formal diagnosis of COVID-19, job loss, loss of loved one, confinement, material hardship) were collected. A Classification and Regression Tree analysis was conducted to uncover the pandemic experiences leading to clinical 'caseness'. Caseness was defined by a score > 9 on the IES-6 symptom measure and further characterized as PTSD or AD depending on whether the Peritraumatic Distress Inventory's life-threat item was endorsed or not.
RESULTS
The participants were predominantly Caucasian (72.8%), women (79.2%), with a university degree (85%), and a mean age of 42.22 (SD = 15.24) years; 3 647 participants (61.7%; 95%CI [60.4, 63.0]) met the threshold for caseness. However, when perceived life-threat was accounted for, only 6.7% (95%CI [6.1, 7.4]) were classified as PTSD cases, and 55% (95%CI [53.7, 56.2]) as AD cases. Among the AD cases, three distinct profiles emerged marked by the following: (i) a worst personal pandemic experience eliciting intense fear, helplessness or horror (in the absence, however, of any life-threat), (ii) a pandemic experience eliciting sadness/grief, and (iii) worrying intensely about the safety of significant others.
CONCLUSIONS
Studies considering the life-threat criterion as met de facto during the pandemic are confusing PTSD for AD on most counts. This misconception is obscuring the various AD-related idioms of distress that have emerged during the pandemic and the actual treatment needs.

Identifiants

pubmed: 35484539
doi: 10.1186/s12888-022-03903-5
pii: 10.1186/s12888-022-03903-5
pmc: PMC9047380
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300

Informations de copyright

© 2022. The Author(s).

Références

Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Eur J Psychotraumatol. 2018 Jan 31;9(1):1425576
pubmed: 29410777
Prim Care Companion CNS Disord. 2013;15(1):
pubmed: 23724345
BMC Psychiatry. 2021 Nov 4;21(1):545
pubmed: 34736442
Ann Behav Med. 2003 Dec;26(3):172-81
pubmed: 14644693
Depress Anxiety. 2011 Sep;28(9):750-69
pubmed: 21910184
Sci Adv. 2020 Oct 14;6(42):
pubmed: 32948511
World J Biol Psychiatry. 2018;19(sup1):S3-S13
pubmed: 30204562
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):405-12
pubmed: 19479171
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Eur J Psychotraumatol. 2021 Jan 26;12(1):1860356
pubmed: 34992743
Psychol Trauma. 2020 Oct;12(7):812-819
pubmed: 32853011
Eur J Psychotraumatol. 2020 Aug 27;11(1):1780832
pubmed: 33029321
World Psychiatry. 2021 Jun;20(2):154-170
pubmed: 34002503
Psychol Med. 2021 Apr;51(6):1052-1053
pubmed: 32216863
JAMA Psychiatry. 2021 Jul 1;78(7):795
pubmed: 34076692
Psychopathology. 2007;40(3):135-46
pubmed: 17284941
Am J Psychiatry. 2001 Sep;158(9):1480-5
pubmed: 11532735
J Trauma. 2001 Aug;51(2):287-92; discussion 292-3
pubmed: 11493786
Psychol Assess. 2008 Jun;20(2):131-8
pubmed: 18557690
Hosp Community Psychiatry. 1986 Mar;37(3):241-9
pubmed: 3957267
J Trauma Stress. 2018 Jun;31(3):321-331
pubmed: 29958336
Neuropsychiatr Dis Treat. 2018 Jan 25;14:375-381
pubmed: 29416339
J Affect Disord. 2021 Mar 15;283:123-129
pubmed: 33548905

Auteurs

Alain Brunet (A)

Research Center of the Douglas Mental Health University Institute (CIUSSS-ODIM), 6875 boulevard LaSalle, Montreal, QC, H4H 1R3, Canada. alain.brunet@mcgill.ca.
Department of Psychiatry, McGill University, Montreal, QC, Canada. alain.brunet@mcgill.ca.

Marjolaine Rivest-Beauregard (M)

Research Center of the Douglas Mental Health University Institute (CIUSSS-ODIM), 6875 boulevard LaSalle, Montreal, QC, H4H 1R3, Canada.
Department of Psychiatry, McGill University, Montreal, QC, Canada.

Michelle Lonergan (M)

Research Center of the Douglas Mental Health University Institute (CIUSSS-ODIM), 6875 boulevard LaSalle, Montreal, QC, H4H 1R3, Canada.
School of Psychology, Ottawa University, Ottawa, ON, Canada.

Sabrina Cipolletta (S)

Department of General Psychology, University of Padua, Padua, Italy.

Andrew Rasmussen (A)

Department of Psychology, Fordham University, New York, NY, USA.

Xiangfei Meng (X)

Research Center of the Douglas Mental Health University Institute (CIUSSS-ODIM), 6875 boulevard LaSalle, Montreal, QC, H4H 1R3, Canada.
Department of Psychiatry, McGill University, Montreal, QC, Canada.

Nematollah Jaafari (N)

Department of Psychiatry, Université de Poitiers, Poitiers, France.

Sara Romero (S)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Julia Superka (J)

Department of Psychology, The New School for Social Research, New York, NY, USA.

Adam D Brown (AD)

Department of Psychology, The New School for Social Research, New York, NY, USA.

Ram P Sapkota (RP)

Research Center of the Douglas Mental Health University Institute (CIUSSS-ODIM), 6875 boulevard LaSalle, Montreal, QC, H4H 1R3, Canada.
Online Therapy Unit, Department of Psychology, University of Regina, Regina, SK, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH